Trial · NCT00392925
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 4 Week Lead-In Period - Non-Randomized | STARTED | Non-Randomized From 4 Week Lead-In | 177 | |
| 4 Week Lead-In Period - Non-Randomized | STARTED | Metreleptin | 0 | |
| 4 Week Lead-In Period - Non-Randomized | STARTED | Pramlintide Acetate | 0 | |
| 4 Week Lead-In Period - Non-Randomized | STARTED | Pramlintide Acetate + Metreleptin | 0 | |
| 4 Week Lead-In Period - Non-Randomized | COMPLETED | Non-Randomized From 4 Week Lead-In | 139 | |
| 4 Week Lead-In Period - Non-Randomized | COMPLETED | Metreleptin | 0 | |
| 4 Week Lead-In Period - Non-Randomized | COMPLETED | Pramlintide Acetate | 0 | |
| 4 Week Lead-In Period - Non-Randomized | COMPLETED | Pramlintide Acetate + Metreleptin | 0 | |
| 4 Week Lead-In Period - Non-Randomized | NOT COMPLETED | Non-Randomized From 4 Week Lead-In | 38 | |
| 4 Week Lead-In Period - Non-Randomized | NOT COMPLETED | Metreleptin | 0 | |
| 4 Week Lead-In Period - Non-Randomized | NOT COMPLETED | Pramlintide Acetate | 0 | |
| 4 Week Lead-In Period - Non-Randomized | NOT COMPLETED | Pramlintide Acetate + Metreleptin | 0 | |
| Randomization to Treatment Group Period | STARTED | Non-Randomized From 4 Week Lead-In | 0 | |
| Randomization to Treatment Group Period | STARTED | Metreleptin | 27 | |
| Randomization to Treatment Group Period | STARTED | Pramlintide Acetate | 56 | |
| Randomization to Treatment Group Period | STARTED | Pramlintide Acetate + Metreleptin | 56 | |
| Randomization to Treatment Group Period | COMPLETED | Non-Randomized From 4 Week Lead-In | 0 | |
| Randomization to Treatment Group Period | COMPLETED | Metreleptin | 19 | |
| Randomization to Treatment Group Period | COMPLETED | Pramlintide Acetate | 37 | |
| Randomization to Treatment Group Period | COMPLETED | Pramlintide Acetate + Metreleptin | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00392925/flow